No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹40Prev. Close
₹40.09Turnover(Lac.)
₹33.9Day's High
₹40.67Day's Low
₹3952 Week's High
₹65.2652 Week's Low
₹11.74Book Value
₹1.5Face Value
₹1Mkt Cap (₹ Cr.)
1,737.94P/E
59.84EPS
0.67Divi. Yield
0.0230 Aug 2025
12:00 AM
AGM
Announcement Date: 30 Aug, 2025
30 Aug 2025
12:00 AM
BookCloser
30 Jan 2026
12:00 AM
Board Meeting
Agenda : Audited Result
4 Jun 2025
12:00 AM
Dividend
Dividend Amount: 0.01
Record Date: 18 Sep, 2025
4 Oct 2025
12:00 AM
EGM
29 Jan 2025
12:00 AM
Split
The contract, valued at ₹24.06 crore, includes the complete scope of supply along with packing, forwarding, insurance and delivery right up to the consignee site in Afghanistan.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 43.79 | 10.95 | 3.91 | 1.57 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 19.05 | 46.69 | 21.38 | 14.78 |
Net Worth | 62.84 | 57.64 | 25.29 | 16.35 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 11.84 | 5.65 | 5.34 | 5.13 |
yoy growth (%) | 109.3 | 5.9 | 4.02 | 6.46 |
Raw materials | -3 | -0.99 | -0.95 | -1.04 |
As % of sales | 25.33 | 17.5 | 17.79 | 20.29 |
Employee costs | -4.4 | -1.96 | -1.27 | -1.09 |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.06 | 0.72 | 0.94 | 1.05 |
Depreciation | -1.47 | -0.96 | -0.73 | -0.46 |
Tax paid | -0.13 | -0.26 | -0.42 | -0.55 |
Working capital | 0.39 | 1.47 | 0.26 | 0.19 |
Other operating items |
| Y/e 31 Mar | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 109.3 | 5.9 | 4.02 | 6.46 |
Op profit growth | -6.61 | 2.11 | 10.28 | 24.06 |
EBIT growth | -90.08 | -26.76 | -6.95 | 15.17 |
Net profit growth | -92.29 | -12.12 | 4.55 | 321.93 |
| Particulars (Rupees in Crores.) | Mar-2025 |
|---|---|
Gross Sales | 32.59 |
Excise Duty | 0 |
Net Sales | 32.59 |
Other Operating Income | 0 |
Other Income | 4.21 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,800.5 | 100.33 | 4,37,878.63 | 705.44 | 0.88 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,067.6 | 64.77 | 1,66,620.03 | 598 | 0.48 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,388 | 67.35 | 1,50,430.54 | 577 | 0.14 | 2,547 | 249.82 |
Dr Reddys Laboratories Ltd DRREDDY | 1,293 | 23.72 | 1,10,068.55 | 90.6 | 0.61 | 4,266.4 | 377.55 |
Lupin Ltd LUPIN | 2,314.85 | 19.48 | 1,07,718.23 | 717.45 | 0.51 | 4,433.96 | 595.67 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / Managing Director
Dakshesh Shah
Executive Director
Payal Mehta
E D & Wholetime Director
Dhruvin Shah
E D & Wholetime Director
Sanskruti Patel
Independent Non Exe. Director
Pinki Nirmal Sagar
Independent Non Exe. Director
Sonal Deepalbhai Gandhi
Independent Non Exe. Director
Sarjeevan Singh
Independent Non Exe. Director
Jitendra shah
Executive Director / Whole Time Director / CFO
Anar Jayesh Patel
E D & Wholetime Director
SHITAL DAKSHESH SHAH
Independent Non Exe. Director
Ritu Kapoor
Company Sec. & Compli. Officer
Arpita Kabraa
3 rd Floor Dev House,
Opp WIAA Office Judges Bungalo,
Gujarat - 380054
Tel: 91-079-66522247/27498515
Website: http://www.shukrapharmaceuticals.com
Email: info@shukrapharmaceuticals.com
9 ShivShakti Indl Es,
J R Boricha Marg, Lower Parel,
Mumbai - 400 011
Tel: 022- 23016761 / 2301
Website: www.purvashare.com
Email: support@purvashare.com
Summary
Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pha...
Read More
Reports by Shukra Pharmaceuticals Ltd
What is the Shukra Pharmaceuticals Ltd share price today?
What is the Market Cap of Shukra Pharmaceuticals Ltd?
What is the PE and PB ratio of Shukra Pharmaceuticals Ltd?
What is the 52 Week High and Low of Shukra Pharmaceuticals Ltd?
What is the CAGR of Shukra Pharmaceuticals Ltd?
What is the shareholding pattern of Shukra Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
